Departments of Anaesthesia.
Neurological Sciences.
J Neurosurg Anesthesiol. 2023 Apr 1;35(2):243-247. doi: 10.1097/ANA.0000000000000824. Epub 2021 Dec 7.
Patients with cervical/upper thoracic compressive myelopathy may have autonomic dysfunction. The composite autonomic severity score (CASS) is the gold standard test to detect autonomic dysfunction, and the self-rated composite autonomic system scale (COMPASS-31) questionnaire is a screening tool to diagnose autonomic dysfunction. This study compared the COMPASS-31 and modified CASS scores for the detection of autonomic dysfunction in patients with compressive myelopathy.
Patients with cervical/upper thoracic compressive myelopathy scheduled for decompressive surgery completed a COMPASS-31 questionnaire and underwent autonomic function tests to calculate the modified CASS score before surgery.
Forty-two patients were included in the study; 19 (45.2%) had mild autonomic dysfunction, 5 (11.9%) had moderate autonomic dysfunction, and 18 (42.9%) had severe autonomic dysfunction. Median (interquartile range) of modified CASS and COMPASS-31 scores were 19 (6.33) and 3 (2.5), respectively. There was a positive correlation between modified CASS and COMPASS-31 scores ( r =0.43; P =0.004). Receiver operating characteristic curve analysis confirmed that COMPASS-31 had fair accuracy for prediction of moderate to severe autonomic dysfunction (area under the curve, 0.74; 95% confidence interval, 0.64-0.82; P =0.009). A cut-off of 30 for total COMPASS-31 score had a sensitivity of 52.2% and specificity of 89.5% to detect moderate to severe autonomic dysfunction, with positive and negative predictive values of 85.7% and 60.7%, respectively.
Patients with cervical/upper thoracic compressive myelopathy had varying degrees of autonomic dysfunction based on the modified CASS. There was a positive correlation between the modified CASS and COMPASS-31 questionnaire. A COMPASS-31 score of >30 30 could be utilized to predict moderate to severe autonomic dysfunction in patients with compressive myelopathy.
患有颈胸段(颈椎/上胸椎)压迫性脊髓病的患者可能存在自主神经功能障碍。综合自主神经严重程度评分(CASS)是检测自主神经功能障碍的金标准,而自评分综合自主系统量表(COMPASS-31)问卷则是诊断自主神经功能障碍的筛查工具。本研究比较了 COMPASS-31 和改良 CASS 评分在检测压迫性脊髓病患者自主神经功能障碍中的作用。
计划行减压手术的颈胸段(颈椎/上胸椎)压迫性脊髓病患者在术前完成 COMPASS-31 问卷并接受自主神经功能测试,以计算改良 CASS 评分。
本研究共纳入 42 例患者;19 例(45.2%)患者存在轻度自主神经功能障碍,5 例(11.9%)患者存在中度自主神经功能障碍,18 例(42.9%)患者存在重度自主神经功能障碍。改良 CASS 和 COMPASS-31 评分的中位数(四分位距)分别为 19(6.33)和 3(2.5)。改良 CASS 与 COMPASS-31 评分之间呈正相关(r=0.43;P=0.004)。受试者工作特征曲线分析证实,COMPASS-31 对预测中重度自主神经功能障碍具有中等准确性(曲线下面积,0.74;95%置信区间,0.64-0.82;P=0.009)。COMPASS-31 总分>30 分的截断值对中重度自主神经功能障碍的敏感性为 52.2%,特异性为 89.5%,阳性预测值和阴性预测值分别为 85.7%和 60.7%。
根据改良 CASS,颈胸段(颈椎/上胸椎)压迫性脊髓病患者存在不同程度的自主神经功能障碍。改良 CASS 与 COMPASS-31 问卷之间存在正相关。COMPASS-31 评分>30 分可用于预测压迫性脊髓病患者的中重度自主神经功能障碍。